Alzheimers and Parkinsons Drug Development Summit on March 18-20, 2025 in Boston, United States
- Event Type: Conference
- Presentation: Physical
- Website URL: http://go.evvnt.com/2732400-0?pid=10008
- Contact E-mail: [email protected]
- Location: Boston, United States
- Venue: Revere Hotel Boston Common
- Date: March 18-20, 2025
- Organization: Hanson Wade
- Conference Tags: medicines medicine health health science science
In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis, reinvigorating the space with new targets, modalities, and technologies. Meanwhile significant advancements to target the likes of α-synuclein, NLRP3 and GBA suggest only a matter of time until a disease-modifying therapy emerges on the scene for Parkinson's too.
Capitalizing on a new era of revitalized hope and momentum, the 13th Alzheimer's and Parkinson's Drug Development Summit returns as the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical, regulatory, and commercial development.
Join industry's premier gathering of 150+ Alzheimer's and Parkinson's experts, with pioneering insights from the likes of Eisai, Eli Lilly, Biogen, and Roche, as they address their most pressing challenges in a collaborative atmosphere to spearhead the next wave of more truly transformative neurodegenerative therapeutics.
URLs:
Tickets: https://go.evvnt.com/2732400-2?pid=10008
Brochure: https://go.evvnt.com/2732400-3?pid=10008
Time: 8:30 AM - 5:00 PM
Prices:
Drug Developer Pricing - Conference + Workshop Day: USD 4597.00,
Drug Developer Pricing - Conference Only: USD 2999.00,
Solution Provider Pricing - Conference + Workshop Day: USD 5563.00,
Solution Provider Pricing - Conference Only: USD 3699.00
Speakers: Alessandro Biffi, Associate Vice President, Eli Lilly and Co., Andre Matta, Executive Director, Ventus Therapeutics, Andrew Kaplan, Principal Scientist, Bristol Myers Squibb, Anick Auger, Head of Pharmacology, Ventus Therapeutics, Aparna Vasanthakumar, Senior Principal Scientist - Research, Abbvie, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Inc., Bruce Morimoto, Vice President - Drug Development, Alto Neuroscience, Carrie Rubel, Scientific Director, Biomarkers, Biogen, Chloe Whitehouse, Senior Specialist, 3D Technologies, Merck and Co, Daniel Klamer, Vice President, Business Development and Scientific Strategy, Anavex, Dean Petkanas, Co-Founder, Chairman and Chief Executive Officer, KannaLife Sciences Inc, Edmond Teng, Senior Group Medical Director, Genentech, Elena Dale, Executive Director, Neuroscience, Bristol Myers Squibb, Eric Siemers, Chief Medical Officer, Acumen Pharmaceuticals, Fraser Bocell, Senior Clinical Outcomes Assessment Scientist, Critical Path Institute (C-Path), Gul Erdemli, Global Program Regulatory Director, Novartis AG, Ivana Rubino, Vice President, Head of Global Medical Alzheimer's Disease and MS, Biogen, Jackie Olley-Williams, Senior Data Scientist, Eisai, Janaky Coomaraswamy, Director, Neuroscience Translational Medicine, Takeda Pharmaceutical Co. Ltd., Kaare Bjerregaard-Andersen, Principal Scientist, Lundbeck, Katie Planey, Chief Executive Officer and Board Member, Acelot, Inc., Kenneth Gregory Pugh, Geriatric Medicine Physician, Norton Healthcare, Luis Oliveira, Senior Associate Director - Research Programs, The Michael J. Fox Foundation for Parkinson's Research, Malú Tansey, Director of the Center for Translational Research in Neurodegenerative Disease, University of Florida, Manal Morsy, Chief Regulatory Officer, Head of Global Regulatory Affairs, Vaxxinity, Manuela Polydoro, Vice President, Head of Translational Medicine, Muna Therapeutics, Maria Maccecchini, Chief Executive Officer, Annovis Bio, Melody Libby, Patient Advocacy Lead, Alzheimer's, Biogen, Michael Erkkinen, Instructor in Neurology, Brigham and Women's Hospital, Neil Cashman, Chief Scientific Officer and Co-Founder, ProMIS Neurosciences, Pallavi Sachdev, Executive Director, Translational Medicine, Eisai, Paul Edison, Professor, Imperial College London, Peter DiBiaso, Patient, The Michael J. Fox Foundation for Parkinson's Research, Ralf Schmid, Associate Director, Pre-Clinical Research, Novartis AG, Rebecca Edelmayer, Vice President, Scientific Engagement, Alzheimer's Association, Sandi See Tai, Chief Devleopment Officer, Lexeo Therapeutics, Sathya Ganesan, US Regulatory Science Lead, UCB S.A., Sean Pintchovski, Vice President, Biology, AcureX Therapeutics, Shane Hegarty, Chief Scientific Officer and Co-Founder, Axonis, Shannon Leslie, Senior Scientist, Johnson and Johnson Services, Inc, Spring Behrouz, Co-founder and CEO, Vincere Biosciences, Steven Arnold, Managing Director, Interdisciplinary Brain Center, Massachusetts General Hopsital, Tammy Dellovade, Senior Research Fellow, Discovery Neuroscience, Abbvie, Tony Bannon, Senior Director - Scientific, Precision Medicine and Neuroscience, Abbvie, Tricia Thornton-Wells, Senior Director and Compound Development Team Leader, Johnson and Johnson Services, Inc, Urs Langen, Lab Head, Roche, William Shrader, Cofounder and Chief Scientific Officer, AcureX Therapeutics, Xavier Langlois, Research Fellow and Head of Tau Pathobiology, Abbvie
Name: Hanson Wade
- December 16, 2024 International Conference on Medical and Health Sciences (ICMHS) - Vientiane, Laos
- December 30, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Karachi, Pakistan
- December 09, 2024 International Conference on Medicine, Health Care and Philosophy (ICMHCP) - Kuala Lumpur, Malaysia
- December 16, 2024 International Conference on Neurology and Epidemiology (ICNE) - Vientiane, Laos
- December 02, 2024 International Conference on Neurology and Epidemiology (ICNE) - Auckland, New Zealand
- December 02, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Sydney, Australia
- December 30, 2024 International Conference on Medical and Health Sciences (ICMHS) - Paris, France
- December 02, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Sydney, Australia
- November 25, 2024 International Conference on Medical and Health Sciences (ICMHS) - London, United Kingdom
- December 30, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Honolulu, United States
- November 25, 2024 International Conference on Neurology and Epidemiology (ICNE) - Bangkok, Thailand
- December 02, 2024 International Conference on Medical and Health Sciences (ICMHS) - Sydney, Australia
- December 30, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Karachi, Pakistan
- December 16, 2024 International Conference on Medical and Health Sciences (ICMHS) - Cairo, Egypt
- December 23, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Dubai, United Arab Emirates
- December 02, 2024 International Conference on Medical and Health Sciences (ICMHS) - Amsterdam, Netherlands
- November 25, 2024 International Conference on Medical and Health Sciences (ICMHS) - Bangkok, Thailand
- December 16, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Cairo, Egypt
- December 23, 2024 International Conference on Medical and Health Sciences (ICMHS) - Dubai, United Arab Emirates
- December 23, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Barcelona, Spain
- December 30, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Vienna, Austria
- November 25, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Bangkok, Thailand
- December 23, 2024 International Conference on Health Psychology, Stress and Coping (ICHPSC) - Dubai, United Arab Emirates
- December 30, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Paris, France
- December 30, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Vienna, Austria
- November 25, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - London, United Kingdom
- December 09, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - London, United Kingdom
- December 30, 2024 International Conference on Neurology and Epidemiology (ICNE) - Vienna, Austria
- December 02, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Amsterdam, Netherlands
- December 16, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Vientiane, Laos
- November 25, 2024 International Conference on Preventive Medicine and Integrative Medicine (ICPMIM) - London, United Kingdom
- December 09, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Kuala Lumpur, Malaysia
- December 02, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Amsterdam, Netherlands
- December 02, 2024 International Conference on Neurology and Epidemiology (ICNE) - Tokyo, Japan
- December 30, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Karachi, Pakistan
- December 09, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - New York, United States
- December 30, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Paris, France
- December 23, 2024 International Conference on Neurology and Epidemiology (ICNE) - Bangkok, Thailand
- December 23, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Barcelona, Spain
- December 02, 2024 International Conference on Neurology and Epidemiology (ICNE) - Sydney, Australia
- December 02, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Amsterdam, Netherlands
- December 02, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Sydney, Australia
- December 02, 2024 International Conference on Health Informatics and Health Information Management (ICHIHIM) - Sydney, Australia
- December 30, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Paris, France
- December 02, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Sydney, Australia
- December 23, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Barcelona, Spain
- December 30, 2024 International Conference on Medical and Health Sciences (ICMHS) - Karachi, Pakistan
- December 16, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Rome, Italy
- December 23, 2024 International Conference on Medical and Health Sciences (ICMHS) - Barcelona, Spain
- December 09, 2024 International Conference on Neurology and Epidemiology (ICNE) - New York, United States
- November 21, 2024 Portfolio Strategy and Decision Making for Biopharma Summit - Boston, United States
- November 21, 2024 NCTE Annual Convention - Boston, United States
- November 21, 2024 Liquid Biopsy Surveillance Summit - Boston, United States
- December 02, 2024 Pharmaceutical and Medical Meeting Planners' Summit - Boston, United States
- December 03, 2024 Personalized Cancer Vaccine Summit - Boston, United States
- December 03, 2024 Cell and Gene Therapy Medical Affairs Summit - Boston, United States
- December 03, 2024 Cell Therapy Analytical Development Summit - Boston, United States
- December 03, 2024 CNS Drug Delivery - Boston, United States
- December 03, 2024 Genome Editing Therapeutics - Boston, United States
- December 04, 2024 Obesity and Metabolic Innovation Forum - Boston, United States